1. Home
  2. APM vs AMZE Comparison

APM vs AMZE Comparison

Compare APM & AMZE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • APM
  • AMZE
  • Stock Information
  • Founded
  • APM 2010
  • AMZE 2019
  • Country
  • APM United Kingdom
  • AMZE United States
  • Employees
  • APM N/A
  • AMZE N/A
  • Industry
  • APM Biotechnology: Pharmaceutical Preparations
  • AMZE Beverages (Production/Distribution)
  • Sector
  • APM Health Care
  • AMZE Consumer Staples
  • Exchange
  • APM Nasdaq
  • AMZE Nasdaq
  • Market Cap
  • APM 6.1M
  • AMZE 5.2M
  • IPO Year
  • APM 2018
  • AMZE 2021
  • Fundamental
  • Price
  • APM $0.99
  • AMZE $10.00
  • Analyst Decision
  • APM
  • AMZE
  • Analyst Count
  • APM 0
  • AMZE 0
  • Target Price
  • APM N/A
  • AMZE N/A
  • AVG Volume (30 Days)
  • APM 92.1K
  • AMZE 71.2K
  • Earning Date
  • APM 07-07-2025
  • AMZE 08-13-2025
  • Dividend Yield
  • APM N/A
  • AMZE N/A
  • EPS Growth
  • APM N/A
  • AMZE N/A
  • EPS
  • APM N/A
  • AMZE N/A
  • Revenue
  • APM N/A
  • AMZE $254,711.00
  • Revenue This Year
  • APM N/A
  • AMZE N/A
  • Revenue Next Year
  • APM N/A
  • AMZE N/A
  • P/E Ratio
  • APM N/A
  • AMZE N/A
  • Revenue Growth
  • APM N/A
  • AMZE N/A
  • 52 Week Low
  • APM $0.46
  • AMZE $5.78
  • 52 Week High
  • APM $7.49
  • AMZE $28.72
  • Technical
  • Relative Strength Index (RSI)
  • APM 47.58
  • AMZE N/A
  • Support Level
  • APM $1.01
  • AMZE N/A
  • Resistance Level
  • APM $1.06
  • AMZE N/A
  • Average True Range (ATR)
  • APM 0.10
  • AMZE 0.00
  • MACD
  • APM -0.02
  • AMZE 0.00
  • Stochastic Oscillator
  • APM 15.68
  • AMZE 0.00

About APM Aptorum Group Limited

Aptorum Group Ltd clinical-stage biopharmaceutical company. It is engaged in the discovery, development, and commercialization of therapeutic assets to treat diseases with unmet medical needs, particularly in oncology (including orphan oncology indications) and infectious diseases. The company operates in two segments: Therapeutics and Non-Therapeutics. The projects are ALS-4, SACT-1, and RPIDD. It is also engaged in providing healthcare services.

About AMZE Amaze Holdings Inc. Common Stock

Amaze Holdings Inc is engaged in producer of low carb, low calorie, premium wines in the United States. The company offers bold, crisp, and creamy wines that embody health, warmth, and a deeper connection to wellness and an active lifestyle. The company currently sell seven proprietary varietals: Cabernet Sauvignon, Pinot Noir, Chardonnay, Sauvignon Blanc, Rose, Sparkling Rose, and a limited Reserve Napa Cabernet Sauvignon.

Share on Social Networks: